nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—L-Cysteine—MGMT—brain cancer	0.0163	1	CrCbGaD
Glycine—GARS—telencephalic ventricle—brain cancer	0.0155	0.0248	CbGeAlD
Glycine—Fluid overload—Carboplatin—brain cancer	0.015	0.111	CcSEcCtD
Glycine—SHMT1—Podofilox—Etoposide—brain cancer	0.0143	1	CbGdCrCtD
Glycine—SLC32A1—Synaptic Vesicle Pathway—SYP—brain cancer	0.0141	0.0668	CbGpPWpGaD
Glycine—ALAS1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0119	0.0566	CbGpPWpGaD
Glycine—SLC6A5—brainstem—brain cancer	0.0113	0.0181	CbGeAlD
Glycine—GLRA2—hindbrain—brain cancer	0.0104	0.0166	CbGeAlD
Glycine—BAAT—endocrine gland—brain cancer	0.00982	0.0158	CbGeAlD
Glycine—GCAT—hindbrain—brain cancer	0.00914	0.0147	CbGeAlD
Glycine—SHMT2—One Carbon Metabolism—DNMT1—brain cancer	0.00832	0.0394	CbGpPWpGaD
Glycine—GSS—Glutathione metabolism—IDH1—brain cancer	0.00793	0.0376	CbGpPWpGaD
Glycine—SLC32A1—telencephalon—brain cancer	0.00787	0.0126	CbGeAlD
Glycine—SHMT2—Trans-sulfuration and one carbon metabolism—DNMT1—brain cancer	0.00747	0.0354	CbGpPWpGaD
Glycine—GARS—hindbrain—brain cancer	0.0073	0.0117	CbGeAlD
Glycine—GRIN2C—hindbrain—brain cancer	0.00718	0.0115	CbGeAlD
Glycine—SLC6A5—spinal cord—brain cancer	0.00703	0.0113	CbGeAlD
Glycine—GATM—hindbrain—brain cancer	0.00693	0.0111	CbGeAlD
Glycine—GRIN2A—ganglion—brain cancer	0.00654	0.0105	CbGeAlD
Glycine—SLC32A1—pituitary gland—brain cancer	0.00641	0.0103	CbGeAlD
Glycine—GLYATL1—endocrine gland—brain cancer	0.00633	0.0102	CbGeAlD
Glycine—BAAT—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.0063	0.0299	CbGpPWpGaD
Glycine—Visual disturbance—Lomustine—brain cancer	0.00625	0.0462	CcSEcCtD
Glycine—SLC6A5—head—brain cancer	0.00624	0.01	CbGeAlD
Glycine—SLC32A1—medulla oblongata—brain cancer	0.00618	0.00992	CbGeAlD
Glycine—SLC6A9—medulla oblongata—brain cancer	0.00597	0.00958	CbGeAlD
Glycine—GLYAT—endocrine gland—brain cancer	0.00595	0.00955	CbGeAlD
Glycine—GLRA2—brainstem—brain cancer	0.00594	0.00953	CbGeAlD
Glycine—GSS—ganglion—brain cancer	0.00572	0.00918	CbGeAlD
Glycine—SLC6A5—central nervous system—brain cancer	0.0057	0.00915	CbGeAlD
Glycine—GPR18—gonad—brain cancer	0.00552	0.00886	CbGeAlD
Glycine—SLC32A1—spinal cord—brain cancer	0.00551	0.00885	CbGeAlD
Glycine—SLC6A9—midbrain—brain cancer	0.00546	0.00876	CbGeAlD
Glycine—SLC6A9—spinal cord—brain cancer	0.00532	0.00855	CbGeAlD
Glycine—GLYATL2—head—brain cancer	0.00531	0.00852	CbGeAlD
Glycine—GCAT—brainstem—brain cancer	0.00524	0.00841	CbGeAlD
Glycine—GLDC—telencephalon—brain cancer	0.00513	0.00824	CbGeAlD
Glycine—Encephalopathy—Carmustine—brain cancer	0.00505	0.0374	CcSEcCtD
Glycine—GRIN2A—hindbrain—brain cancer	0.00496	0.00796	CbGeAlD
Glycine—SLC36A1—hindbrain—brain cancer	0.00493	0.00791	CbGeAlD
Glycine—SHMT1—One Carbon Metabolism—DNMT1—brain cancer	0.0049	0.0232	CbGpPWpGaD
Glycine—SLC32A1—head—brain cancer	0.0049	0.00786	CbGeAlD
Glycine—GLYATL2—central nervous system—brain cancer	0.00485	0.00778	CbGeAlD
Glycine—PIPOX—telencephalon—brain cancer	0.00479	0.00769	CbGeAlD
Glycine—Coma—Procarbazine—brain cancer	0.00473	0.035	CcSEcCtD
Glycine—SLC6A9—head—brain cancer	0.00473	0.0076	CbGeAlD
Glycine—GLRA3—head—brain cancer	0.00473	0.0076	CbGeAlD
Glycine—AGXT2—gonad—brain cancer	0.00459	0.00736	CbGeAlD
Glycine—SLC6A5—brain—brain cancer	0.00453	0.00726	CbGeAlD
Glycine—ALAS2—endocrine gland—brain cancer	0.00451	0.00723	CbGeAlD
Glycine—SLC32A1—central nervous system—brain cancer	0.00447	0.00718	CbGeAlD
Glycine—Lung disorder—Temozolomide—brain cancer	0.00443	0.0327	CcSEcCtD
Glycine—GNMT—pituitary gland—brain cancer	0.00441	0.00708	CbGeAlD
Glycine—SHMT1—Trans-sulfuration and one carbon metabolism—DNMT1—brain cancer	0.0044	0.0209	CbGpPWpGaD
Glycine—SLC32A1—cerebellum—brain cancer	0.00437	0.00702	CbGeAlD
Glycine—SLC6A9—central nervous system—brain cancer	0.00432	0.00693	CbGeAlD
Glycine—GLRA3—central nervous system—brain cancer	0.00432	0.00693	CbGeAlD
Glycine—GSS—Trans-sulfuration and one carbon metabolism—DNMT1—brain cancer	0.00429	0.0203	CbGpPWpGaD
Glycine—GARS—brainstem—brain cancer	0.00418	0.00671	CbGeAlD
Glycine—GLDC—pituitary gland—brain cancer	0.00418	0.00671	CbGeAlD
Glycine—GPR18—endocrine gland—brain cancer	0.00417	0.00669	CbGeAlD
Glycine—GRIN2C—brainstem—brain cancer	0.00411	0.0066	CbGeAlD
Glycine—AGXT—endocrine gland—brain cancer	0.00408	0.00654	CbGeAlD
Glycine—ALAS1—telencephalon—brain cancer	0.00407	0.00654	CbGeAlD
Glycine—GLDC—medulla oblongata—brain cancer	0.00403	0.00647	CbGeAlD
Glycine—GATM—brainstem—brain cancer	0.00397	0.00637	CbGeAlD
Glycine—Visual impairment—Lomustine—brain cancer	0.00395	0.0292	CcSEcCtD
Glycine—GCSH—endocrine gland—brain cancer	0.00391	0.00627	CbGeAlD
Glycine—PIPOX—pituitary gland—brain cancer	0.0039	0.00626	CbGeAlD
Glycine—GCSH—head—brain cancer	0.00386	0.00619	CbGeAlD
Glycine—GLYATL2—brain—brain cancer	0.00385	0.00618	CbGeAlD
Glycine—GCAT—pituitary gland—brain cancer	0.00379	0.00608	CbGeAlD
Glycine—GLYAT—Biological oxidations—CYP2C9—brain cancer	0.00378	0.0179	CbGpPWpGaD
Glycine—GLYATL1—Biological oxidations—CYP2C9—brain cancer	0.00378	0.0179	CbGpPWpGaD
Glycine—GLYATL2—Biological oxidations—CYP2C9—brain cancer	0.00378	0.0179	CbGpPWpGaD
Glycine—PIPOX—medulla oblongata—brain cancer	0.00377	0.00604	CbGeAlD
Glycine—GLYATL1—Metapathway biotransformation—CYP2C9—brain cancer	0.00373	0.0176	CbGpPWpGaD
Glycine—GLYATL2—Metapathway biotransformation—CYP2C9—brain cancer	0.00373	0.0176	CbGpPWpGaD
Glycine—GLYAT—Metapathway biotransformation—CYP2C9—brain cancer	0.00373	0.0176	CbGpPWpGaD
Glycine—GARS—telencephalon—brain cancer	0.00371	0.00596	CbGeAlD
Glycine—GLDC—midbrain—brain cancer	0.00369	0.00592	CbGeAlD
Glycine—GLRA1—central nervous system—brain cancer	0.00367	0.0059	CbGeAlD
Glycine—GCAT—medulla oblongata—brain cancer	0.00365	0.00586	CbGeAlD
Glycine—GRIN2C—telencephalon—brain cancer	0.00365	0.00586	CbGeAlD
Glycine—GLDC—spinal cord—brain cancer	0.0036	0.00577	CbGeAlD
Glycine—AGXT—cerebellum—brain cancer	0.00359	0.00576	CbGeAlD
Glycine—SHMT2—Vitamin B12 Metabolism—SOD2—brain cancer	0.00358	0.017	CbGpPWpGaD
Glycine—BAAT—Metapathway biotransformation—CYP2C9—brain cancer	0.00355	0.0168	CbGpPWpGaD
Glycine—SLC32A1—brain—brain cancer	0.00355	0.0057	CbGeAlD
Glycine—GATM—telencephalon—brain cancer	0.00352	0.00566	CbGeAlD
Glycine—GCSH—central nervous system—brain cancer	0.00352	0.00565	CbGeAlD
Glycine—AGXT2—endocrine gland—brain cancer	0.00347	0.00556	CbGeAlD
Glycine—GPR18—GPCRs, Other—SMO—brain cancer	0.00344	0.0163	CbGpPWpGaD
Glycine—GCSH—cerebellum—brain cancer	0.00344	0.00552	CbGeAlD
Glycine—PIPOX—midbrain—brain cancer	0.00344	0.00552	CbGeAlD
Glycine—SLC6A9—brain—brain cancer	0.00343	0.0055	CbGeAlD
Glycine—GLRA3—brain—brain cancer	0.00343	0.0055	CbGeAlD
Glycine—GNMT—endocrine gland—brain cancer	0.00342	0.00548	CbGeAlD
Glycine—PIPOX—spinal cord—brain cancer	0.00336	0.00539	CbGeAlD
Glycine—GCAT—midbrain—brain cancer	0.00334	0.00536	CbGeAlD
Glycine—ALAS1—pituitary gland—brain cancer	0.00332	0.00533	CbGeAlD
Glycine—GLRA2—head—brain cancer	0.00328	0.00527	CbGeAlD
Glycine—GCAT—spinal cord—brain cancer	0.00326	0.00523	CbGeAlD
Glycine—GLDC—endocrine gland—brain cancer	0.00324	0.0052	CbGeAlD
Glycine—SHMT2—telencephalon—brain cancer	0.00323	0.00518	CbGeAlD
Glycine—ALAS1—medulla oblongata—brain cancer	0.0032	0.00514	CbGeAlD
Glycine—GLDC—head—brain cancer	0.0032	0.00513	CbGeAlD
Glycine—Angina pectoris—Procarbazine—brain cancer	0.00317	0.0234	CcSEcCtD
Glycine—GARS—gonad—brain cancer	0.0031	0.00497	CbGeAlD
Glycine—GLRB—telencephalon—brain cancer	0.00303	0.00486	CbGeAlD
Glycine—PIPOX—endocrine gland—brain cancer	0.00302	0.00485	CbGeAlD
Glycine—GARS—pituitary gland—brain cancer	0.00302	0.00485	CbGeAlD
Glycine—GLRA2—central nervous system—brain cancer	0.00299	0.00481	CbGeAlD
Glycine—PIPOX—head—brain cancer	0.00298	0.00479	CbGeAlD
Glycine—Coma—Carmustine—brain cancer	0.00296	0.0219	CcSEcCtD
Glycine—GATM—gonad—brain cancer	0.00294	0.00472	CbGeAlD
Glycine—GCAT—endocrine gland—brain cancer	0.00293	0.00471	CbGeAlD
Glycine—GLRA2—cerebellum—brain cancer	0.00293	0.0047	CbGeAlD
Glycine—ALAS1—midbrain—brain cancer	0.00293	0.0047	CbGeAlD
Glycine—GLDC—central nervous system—brain cancer	0.00292	0.00468	CbGeAlD
Glycine—GARS—medulla oblongata—brain cancer	0.00292	0.00468	CbGeAlD
Glycine—SHMT2—Folate Metabolism—SOD2—brain cancer	0.00291	0.0138	CbGpPWpGaD
Glycine—GCAT—head—brain cancer	0.00289	0.00465	CbGeAlD
Glycine—GRIN2C—medulla oblongata—brain cancer	0.00287	0.0046	CbGeAlD
Glycine—ALAS1—spinal cord—brain cancer	0.00286	0.00458	CbGeAlD
Glycine—Cardiovascular disorder—Etoposide—brain cancer	0.00285	0.0211	CcSEcCtD
Glycine—GLDC—cerebellum—brain cancer	0.00285	0.00458	CbGeAlD
Glycine—Pain—Carboplatin—brain cancer	0.00285	0.0211	CcSEcCtD
Glycine—GRIN2A—brainstem—brain cancer	0.00284	0.00456	CbGeAlD
Glycine—SLC36A1—brainstem—brain cancer	0.00282	0.00453	CbGeAlD
Glycine—GCSH—brain—brain cancer	0.0028	0.00449	CbGeAlD
Glycine—PIPOX—central nervous system—brain cancer	0.00272	0.00437	CbGeAlD
Glycine—Thrombophlebitis—Carmustine—brain cancer	0.00272	0.0201	CcSEcCtD
Glycine—SHMT2—gonad—brain cancer	0.00269	0.00433	CbGeAlD
Glycine—GARS—midbrain—brain cancer	0.00267	0.00428	CbGeAlD
Glycine—PIPOX—cerebellum—brain cancer	0.00266	0.00427	CbGeAlD
Glycine—GCAT—central nervous system—brain cancer	0.00264	0.00424	CbGeAlD
Glycine—SHMT2—pituitary gland—brain cancer	0.00263	0.00422	CbGeAlD
Glycine—Thrombophlebitis—Temozolomide—brain cancer	0.00263	0.0194	CcSEcCtD
Glycine—GARS—spinal cord—brain cancer	0.0026	0.00417	CbGeAlD
Glycine—GCAT—cerebellum—brain cancer	0.00258	0.00415	CbGeAlD
Glycine—ALAS1—endocrine gland—brain cancer	0.00257	0.00413	CbGeAlD
Glycine—ALAS1—head—brain cancer	0.00254	0.00407	CbGeAlD
Glycine—GATM—midbrain—brain cancer	0.00253	0.00406	CbGeAlD
Glycine—GRIN2A—telencephalon—brain cancer	0.00252	0.00405	CbGeAlD
Glycine—SLC36A1—telencephalon—brain cancer	0.00251	0.00402	CbGeAlD
Glycine—GSS—brainstem—brain cancer	0.00249	0.00399	CbGeAlD
Glycine—GATM—spinal cord—brain cancer	0.00247	0.00396	CbGeAlD
Glycine—GLRB—pituitary gland—brain cancer	0.00246	0.00395	CbGeAlD
Glycine—SHMT1—gonad—brain cancer	0.00245	0.00394	CbGeAlD
Glycine—GNMT—brain—brain cancer	0.00244	0.00392	CbGeAlD
Glycine—Thirst—Temozolomide—brain cancer	0.00239	0.0177	CcSEcCtD
Glycine—GLRB—medulla oblongata—brain cancer	0.00238	0.00382	CbGeAlD
Glycine—GLRA2—brain—brain cancer	0.00238	0.00382	CbGeAlD
Glycine—Hyponatraemia—Carmustine—brain cancer	0.00236	0.0175	CcSEcCtD
Glycine—GARS—endocrine gland—brain cancer	0.00234	0.00376	CbGeAlD
Glycine—Chills—Procarbazine—brain cancer	0.00233	0.0173	CcSEcCtD
Glycine—SHMT2—midbrain—brain cancer	0.00232	0.00372	CbGeAlD
Glycine—GLDC—brain—brain cancer	0.00232	0.00372	CbGeAlD
Glycine—ALAS1—central nervous system—brain cancer	0.00232	0.00372	CbGeAlD
Glycine—GARS—head—brain cancer	0.00231	0.00371	CbGeAlD
Glycine—GRIN2C—head—brain cancer	0.00227	0.00365	CbGeAlD
Glycine—ALAS1—cerebellum—brain cancer	0.00226	0.00363	CbGeAlD
Glycine—GATM—endocrine gland—brain cancer	0.00222	0.00357	CbGeAlD
Glycine—GSS—telencephalon—brain cancer	0.00221	0.00354	CbGeAlD
Glycine—GATM—head—brain cancer	0.00219	0.00352	CbGeAlD
Glycine—GLRB—midbrain—brain cancer	0.00217	0.00349	CbGeAlD
Glycine—GSS—Biological oxidations—CYP2C9—brain cancer	0.00217	0.0103	CbGpPWpGaD
Glycine—PIPOX—brain—brain cancer	0.00216	0.00347	CbGeAlD
Glycine—GSS—Metapathway biotransformation—CYP2C9—brain cancer	0.00214	0.0101	CbGpPWpGaD
Glycine—GLRB—spinal cord—brain cancer	0.00212	0.0034	CbGeAlD
Glycine—Dehydration—Temozolomide—brain cancer	0.00211	0.0156	CcSEcCtD
Glycine—GARS—central nervous system—brain cancer	0.00211	0.00339	CbGeAlD
Glycine—GLRA3—Ion channel transport—TRPC6—brain cancer	0.00211	0.00998	CbGpPWpGaD
Glycine—GLRA2—Ion channel transport—TRPC6—brain cancer	0.00211	0.00998	CbGpPWpGaD
Glycine—GCAT—brain—brain cancer	0.0021	0.00337	CbGeAlD
Glycine—SLC36A1—gonad—brain cancer	0.00209	0.00336	CbGeAlD
Glycine—GRIN2C—central nervous system—brain cancer	0.00208	0.00333	CbGeAlD
Glycine—SHMT2—Vitamin B12 Metabolism—RELA—brain cancer	0.00207	0.0098	CbGpPWpGaD
Glycine—GARS—cerebellum—brain cancer	0.00206	0.00331	CbGeAlD
Glycine—SHMT2—endocrine gland—brain cancer	0.00204	0.00327	CbGeAlD
Glycine—GRIN2C—cerebellum—brain cancer	0.00203	0.00326	CbGeAlD
Glycine—SHMT2—head—brain cancer	0.00201	0.00323	CbGeAlD
Glycine—GATM—central nervous system—brain cancer	0.002	0.00321	CbGeAlD
Glycine—GPR18—GPCR ligand binding—PTCH2—brain cancer	0.002	0.00947	CbGpPWpGaD
Glycine—GRIN2A—medulla oblongata—brain cancer	0.00198	0.00318	CbGeAlD
Glycine—Convulsion—Procarbazine—brain cancer	0.00196	0.0145	CcSEcCtD
Glycine—GATM—cerebellum—brain cancer	0.00196	0.00314	CbGeAlD
Glycine—GLRB—head—brain cancer	0.00188	0.00302	CbGeAlD
Glycine—SLC6A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.00187	0.00884	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—S100A10—brain cancer	0.00187	0.00884	CbGpPWpGaD
Glycine—SHMT1—endocrine gland—brain cancer	0.00185	0.00298	CbGeAlD
Glycine—Vomiting—Lomustine—brain cancer	0.00185	0.0137	CcSEcCtD
Glycine—Oedema—Procarbazine—brain cancer	0.00185	0.0137	CcSEcCtD
Glycine—GSS—gonad—brain cancer	0.00184	0.00296	CbGeAlD
Glycine—ALAS1—brain—brain cancer	0.00184	0.00295	CbGeAlD
Glycine—SHMT2—central nervous system—brain cancer	0.00184	0.00295	CbGeAlD
Glycine—SHMT1—head—brain cancer	0.00183	0.00294	CbGeAlD
Glycine—GRIN2A—midbrain—brain cancer	0.00181	0.00291	CbGeAlD
Glycine—Chills—Hydroxyurea—brain cancer	0.00181	0.0134	CcSEcCtD
Glycine—Tachycardia—Procarbazine—brain cancer	0.0018	0.0133	CcSEcCtD
Glycine—GSS—pituitary gland—brain cancer	0.0018	0.00288	CbGeAlD
Glycine—SHMT2—cerebellum—brain cancer	0.00179	0.00288	CbGeAlD
Glycine—GRIN2A—spinal cord—brain cancer	0.00177	0.00284	CbGeAlD
Glycine—GPR18—GPCR downstream signaling—OR4C12—brain cancer	0.00175	0.0083	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—OR14C36—brain cancer	0.00175	0.0083	CbGpPWpGaD
Glycine—GSS—medulla oblongata—brain cancer	0.00173	0.00278	CbGeAlD
Glycine—Nausea—Lomustine—brain cancer	0.00173	0.0128	CcSEcCtD
Glycine—Hypotension—Procarbazine—brain cancer	0.00173	0.0128	CcSEcCtD
Glycine—GLRB—central nervous system—brain cancer	0.00172	0.00276	CbGeAlD
Glycine—GLRB—Ion channel transport—TRPC6—brain cancer	0.00172	0.00813	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—SOD2—brain cancer	0.00172	0.00813	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—RELA—brain cancer	0.00168	0.00798	CbGpPWpGaD
Glycine—GLRB—cerebellum—brain cancer	0.00168	0.0027	CbGeAlD
Glycine—GARS—brain—brain cancer	0.00167	0.00269	CbGeAlD
Glycine—SHMT1—central nervous system—brain cancer	0.00167	0.00268	CbGeAlD
Glycine—GRIN2C—brain—brain cancer	0.00165	0.00264	CbGeAlD
Glycine—SHMT1—cerebellum—brain cancer	0.00163	0.00262	CbGeAlD
Glycine—GPR18—Signaling by GPCR—OR4C12—brain cancer	0.00159	0.00754	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—OR14C36—brain cancer	0.00159	0.00754	CbGpPWpGaD
Glycine—GRIN2A—endocrine gland—brain cancer	0.00159	0.00255	CbGeAlD
Glycine—GATM—brain—brain cancer	0.00159	0.00255	CbGeAlD
Glycine—SLC32A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00159	0.00752	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00159	0.00752	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—S100A10—brain cancer	0.00159	0.00752	CbGpPWpGaD
Glycine—GSS—midbrain—brain cancer	0.00158	0.00254	CbGeAlD
Glycine—SLC36A1—endocrine gland—brain cancer	0.00158	0.00254	CbGeAlD
Glycine—Pain—Procarbazine—brain cancer	0.00158	0.0117	CcSEcCtD
Glycine—GRIN2A—head—brain cancer	0.00157	0.00252	CbGeAlD
Glycine—Visual impairment—Carmustine—brain cancer	0.00157	0.0116	CcSEcCtD
Glycine—SLC36A1—head—brain cancer	0.00156	0.00251	CbGeAlD
Glycine—GSS—spinal cord—brain cancer	0.00155	0.00248	CbGeAlD
Glycine—Convulsion—Hydroxyurea—brain cancer	0.00152	0.0112	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—IL2—brain cancer	0.00152	0.00718	CbGpPWpGaD
Glycine—Visual impairment—Temozolomide—brain cancer	0.00152	0.0112	CcSEcCtD
Glycine—Urticaria—Procarbazine—brain cancer	0.00147	0.0109	CcSEcCtD
Glycine—SHMT2—brain—brain cancer	0.00146	0.00234	CbGeAlD
Glycine—GRIN2A—central nervous system—brain cancer	0.00143	0.0023	CbGeAlD
Glycine—Oedema—Hydroxyurea—brain cancer	0.00143	0.0106	CcSEcCtD
Glycine—SLC36A1—central nervous system—brain cancer	0.00142	0.00229	CbGeAlD
Glycine—Chills—Temozolomide—brain cancer	0.00141	0.0104	CcSEcCtD
Glycine—GRIN2A—cerebellum—brain cancer	0.0014	0.00225	CbGeAlD
Glycine—SLC36A1—cerebellum—brain cancer	0.00139	0.00224	CbGeAlD
Glycine—GSS—endocrine gland—brain cancer	0.00139	0.00223	CbGeAlD
Glycine—BAAT—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00138	0.00655	CbGpPWpGaD
Glycine—GSS—head—brain cancer	0.00137	0.00221	CbGeAlD
Glycine—Back pain—Carmustine—brain cancer	0.00137	0.0101	CcSEcCtD
Glycine—GLRB—brain—brain cancer	0.00137	0.00219	CbGeAlD
Glycine—Hypersensitivity—Procarbazine—brain cancer	0.00136	0.0101	CcSEcCtD
Glycine—GLRA1—Ion channel transport—TRPC6—brain cancer	0.00136	0.00643	CbGpPWpGaD
Glycine—SLC16A10—gonad—brain cancer	0.00135	0.00217	CbGeAlD
Glycine—Vision blurred—Carmustine—brain cancer	0.00134	0.00988	CcSEcCtD
Glycine—SHMT1—brain—brain cancer	0.00133	0.00213	CbGeAlD
Glycine—Back pain—Temozolomide—brain cancer	0.00132	0.0098	CcSEcCtD
Glycine—GLRB—Transmembrane transport of small molecules—S100A10—brain cancer	0.00129	0.00613	CbGpPWpGaD
Glycine—Vision blurred—Temozolomide—brain cancer	0.00129	0.00955	CcSEcCtD
Glycine—Diarrhoea—Procarbazine—brain cancer	0.00126	0.00936	CcSEcCtD
Glycine—GSS—central nervous system—brain cancer	0.00125	0.00201	CbGeAlD
Glycine—Vertigo—Temozolomide—brain cancer	0.00123	0.0091	CcSEcCtD
Glycine—Convulsion—Carmustine—brain cancer	0.00123	0.00908	CcSEcCtD
Glycine—GSS—cerebellum—brain cancer	0.00123	0.00197	CbGeAlD
Glycine—Pain—Hydroxyurea—brain cancer	0.00122	0.00905	CcSEcCtD
Glycine—Dizziness—Procarbazine—brain cancer	0.00122	0.00904	CcSEcCtD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00119	0.00566	CbGpPWpGaD
Glycine—Convulsion—Temozolomide—brain cancer	0.00119	0.00878	CcSEcCtD
Glycine—Vomiting—Procarbazine—brain cancer	0.00118	0.00869	CcSEcCtD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—CDK4—brain cancer	0.00117	0.00553	CbGpPWpGaD
Glycine—Oedema—Carmustine—brain cancer	0.00116	0.00856	CcSEcCtD
Glycine—GRIN2A—brain—brain cancer	0.00114	0.00183	CbGeAlD
Glycine—SLC36A1—brain—brain cancer	0.00113	0.00182	CbGeAlD
Glycine—Chills—Etoposide—brain cancer	0.00113	0.00836	CcSEcCtD
Glycine—Tachycardia—Carmustine—brain cancer	0.00113	0.00835	CcSEcCtD
Glycine—Oedema—Temozolomide—brain cancer	0.00112	0.00827	CcSEcCtD
Glycine—Nausea—Procarbazine—brain cancer	0.0011	0.00812	CcSEcCtD
Glycine—Hypotension—Carmustine—brain cancer	0.00108	0.00799	CcSEcCtD
Glycine—Back pain—Etoposide—brain cancer	0.00106	0.00784	CcSEcCtD
Glycine—Hypersensitivity—Hydroxyurea—brain cancer	0.00105	0.0078	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—SHH—brain cancer	0.00103	0.00488	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PTCH2—brain cancer	0.00103	0.00486	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00102	0.00485	CbGpPWpGaD
Glycine—SLC16A10—endocrine gland—brain cancer	0.00102	0.00164	CbGeAlD
Glycine—BAAT—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00101	0.00479	CbGpPWpGaD
Glycine—GSS—brain—brain cancer	0.000996	0.0016	CbGeAlD
Glycine—SHMT1—Folate Metabolism—RELA—brain cancer	0.000993	0.0047	CbGpPWpGaD
Glycine—Pain—Carmustine—brain cancer	0.000989	0.00732	CcSEcCtD
Glycine—Vertigo—Etoposide—brain cancer	0.000985	0.00728	CcSEcCtD
Glycine—Diarrhoea—Hydroxyurea—brain cancer	0.000979	0.00724	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—PTCH1—brain cancer	0.000976	0.00462	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—SMO—brain cancer	0.000976	0.00462	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—TP53—brain cancer	0.000974	0.00461	CbGpPWpGaD
Glycine—Pain—Temozolomide—brain cancer	0.000956	0.00707	CcSEcCtD
Glycine—Convulsion—Etoposide—brain cancer	0.00095	0.00702	CcSEcCtD
Glycine—Dizziness—Hydroxyurea—brain cancer	0.000946	0.007	CcSEcCtD
Glycine—GPR18—Signaling Pathways—OR14C36—brain cancer	0.000941	0.00445	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—OR4C12—brain cancer	0.000941	0.00445	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000912	0.00432	CbGpPWpGaD
Glycine—Vomiting—Hydroxyurea—brain cancer	0.00091	0.00673	CcSEcCtD
Glycine—SLC16A10—cerebellum—brain cancer	0.000898	0.00144	CbGeAlD
Glycine—SHMT1—Folate Metabolism—IL2—brain cancer	0.000894	0.00423	CbGpPWpGaD
Glycine—Urticaria—Temozolomide—brain cancer	0.000888	0.00657	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—ABR—brain cancer	0.000887	0.0042	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000874	0.00414	CbGpPWpGaD
Glycine—Tachycardia—Etoposide—brain cancer	0.000873	0.00646	CcSEcCtD
Glycine—SLC6A5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000863	0.00408	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000863	0.00408	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CYP2C9—brain cancer	0.000853	0.00404	CbGpPWpGaD
Glycine—Hypersensitivity—Carmustine—brain cancer	0.000852	0.0063	CcSEcCtD
Glycine—Nausea—Hydroxyurea—brain cancer	0.00085	0.00629	CcSEcCtD
Glycine—Hypotension—Etoposide—brain cancer	0.000836	0.00618	CcSEcCtD
Glycine—Hypersensitivity—Temozolomide—brain cancer	0.000824	0.00609	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—ABR—brain cancer	0.000805	0.00381	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DTX2—brain cancer	0.0008	0.00379	CbGpPWpGaD
Glycine—Diarrhoea—Carmustine—brain cancer	0.000791	0.00585	CcSEcCtD
Glycine—Dizziness—Carmustine—brain cancer	0.000765	0.00566	CcSEcCtD
Glycine—Pain—Etoposide—brain cancer	0.000765	0.00566	CcSEcCtD
Glycine—Diarrhoea—Temozolomide—brain cancer	0.000765	0.00566	CcSEcCtD
Glycine—Dizziness—Temozolomide—brain cancer	0.000739	0.00547	CcSEcCtD
Glycine—Vomiting—Carmustine—brain cancer	0.000735	0.00544	CcSEcCtD
Glycine—GLRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000733	0.00347	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000733	0.00347	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000733	0.00347	CbGpPWpGaD
Glycine—ALAS2—Metabolism—BSG—brain cancer	0.000725	0.00343	CbGpPWpGaD
Glycine—Vomiting—Temozolomide—brain cancer	0.000711	0.00526	CcSEcCtD
Glycine—Urticaria—Etoposide—brain cancer	0.000711	0.00526	CcSEcCtD
Glycine—Nausea—Carmustine—brain cancer	0.000687	0.00508	CcSEcCtD
Glycine—SHMT1—Disease—DTX2—brain cancer	0.000673	0.00319	CbGpPWpGaD
Glycine—Nausea—Temozolomide—brain cancer	0.000664	0.00491	CcSEcCtD
Glycine—Hypersensitivity—Etoposide—brain cancer	0.000659	0.00487	CcSEcCtD
Glycine—GLYATL2—Metabolism—CYP2C9—brain cancer	0.000646	0.00306	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CYP2C9—brain cancer	0.000646	0.00306	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CYP2C9—brain cancer	0.000646	0.00306	CbGpPWpGaD
Glycine—GATM—Metabolism—CYP2C9—brain cancer	0.000646	0.00306	CbGpPWpGaD
Glycine—ALAS2—Metabolism—IDH1—brain cancer	0.000623	0.00295	CbGpPWpGaD
Glycine—BAAT—Metabolism—CYP2C9—brain cancer	0.000616	0.00292	CbGpPWpGaD
Glycine—Diarrhoea—Etoposide—brain cancer	0.000612	0.00453	CcSEcCtD
Glycine—GPR18—Signaling Pathways—PTCH2—brain cancer	0.000606	0.00287	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—brain cancer	0.000605	0.00287	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000598	0.00283	CbGpPWpGaD
Glycine—Dizziness—Etoposide—brain cancer	0.000591	0.00437	CcSEcCtD
Glycine—GPR18—Signaling Pathways—HES5—brain cancer	0.000587	0.00278	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TP53—brain cancer	0.000574	0.00272	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STRADA—brain cancer	0.00057	0.0027	CbGpPWpGaD
Glycine—Vomiting—Etoposide—brain cancer	0.000569	0.00421	CcSEcCtD
Glycine—GARS—Gene Expression—DNMT1—brain cancer	0.000565	0.00267	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—TRPC6—brain cancer	0.000561	0.00266	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—S100A10—brain cancer	0.000554	0.00263	CbGpPWpGaD
Glycine—GLYAT—Metabolism—BSG—brain cancer	0.000549	0.0026	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—BSG—brain cancer	0.000549	0.0026	CbGpPWpGaD
Glycine—AGXT—Metabolism—CYP2C9—brain cancer	0.000549	0.0026	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—BSG—brain cancer	0.000549	0.0026	CbGpPWpGaD
Glycine—GATM—Metabolism—BSG—brain cancer	0.000549	0.0026	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CYP2C9—brain cancer	0.000532	0.00252	CbGpPWpGaD
Glycine—Nausea—Etoposide—brain cancer	0.000531	0.00393	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—SHH—brain cancer	0.000529	0.0025	CbGpPWpGaD
Glycine—BAAT—Metabolism—BSG—brain cancer	0.000524	0.00248	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—TRPC6—brain cancer	0.00051	0.00241	CbGpPWpGaD
Glycine—GARS—Gene Expression—ESR2—brain cancer	0.000507	0.0024	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—SMO—brain cancer	0.000501	0.00237	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PTCH1—brain cancer	0.000501	0.00237	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.000497	0.00235	CbGpPWpGaD
Glycine—SHMT1—Disease—HES5—brain cancer	0.000494	0.00234	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ENO2—brain cancer	0.000493	0.00233	CbGpPWpGaD
Glycine—GARS—Gene Expression—NOTCH2—brain cancer	0.00048	0.00227	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ABR—brain cancer	0.000476	0.00225	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000473	0.00224	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—IDH1—brain cancer	0.000472	0.00224	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—IDH1—brain cancer	0.000472	0.00224	CbGpPWpGaD
Glycine—GATM—Metabolism—IDH1—brain cancer	0.000472	0.00224	CbGpPWpGaD
Glycine—GLYAT—Metabolism—IDH1—brain cancer	0.000472	0.00224	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP2C9—brain cancer	0.000467	0.00221	CbGpPWpGaD
Glycine—AGXT—Metabolism—BSG—brain cancer	0.000467	0.00221	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GLI2—brain cancer	0.000459	0.00218	CbGpPWpGaD
Glycine—ALAS1—Metabolism—BSG—brain cancer	0.000452	0.00214	CbGpPWpGaD
Glycine—BAAT—Metabolism—IDH1—brain cancer	0.000451	0.00213	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GLI1—brain cancer	0.000432	0.00205	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000421	0.00199	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—VAV1—brain cancer	0.000421	0.00199	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SUFU—brain cancer	0.000409	0.00194	CbGpPWpGaD
Glycine—GARS—Gene Expression—SIRT1—brain cancer	0.000408	0.00193	CbGpPWpGaD
Glycine—AGXT—Metabolism—IDH1—brain cancer	0.000402	0.0019	CbGpPWpGaD
Glycine—AGXT2—Metabolism—BSG—brain cancer	0.000397	0.00188	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GFAP—brain cancer	0.000395	0.00187	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TP53—brain cancer	0.00039	0.00185	CbGpPWpGaD
Glycine—ALAS1—Metabolism—IDH1—brain cancer	0.000389	0.00184	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—VAV1—brain cancer	0.000382	0.00181	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP2C9—brain cancer	0.000381	0.0018	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HEY1—brain cancer	0.000374	0.00177	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ENO2—brain cancer	0.000373	0.00177	CbGpPWpGaD
Glycine—GATM—Metabolism—ENO2—brain cancer	0.000373	0.00177	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ENO2—brain cancer	0.000373	0.00177	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ENO2—brain cancer	0.000373	0.00177	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP2C9—brain cancer	0.000371	0.00176	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DLL1—brain cancer	0.000367	0.00174	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000367	0.00174	CbGpPWpGaD
Glycine—BAAT—Metabolism—ENO2—brain cancer	0.000356	0.00169	CbGpPWpGaD
Glycine—AGXT2—Metabolism—IDH1—brain cancer	0.000342	0.00162	CbGpPWpGaD
Glycine—SHMT1—Disease—IDH1—brain cancer	0.000332	0.00157	CbGpPWpGaD
Glycine—SHMT1—Metabolism—BSG—brain cancer	0.000324	0.00153	CbGpPWpGaD
Glycine—AGXT—Metabolism—ENO2—brain cancer	0.000318	0.0015	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000317	0.0015	CbGpPWpGaD
Glycine—GSS—Metabolism—BSG—brain cancer	0.000316	0.00149	CbGpPWpGaD
Glycine—SHMT1—Disease—HEY1—brain cancer	0.000315	0.00149	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SHH—brain cancer	0.000312	0.00148	CbGpPWpGaD
Glycine—SHMT1—Disease—DLL1—brain cancer	0.000309	0.00146	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ENO2—brain cancer	0.000308	0.00146	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TRPC6—brain cancer	0.000301	0.00143	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—brain cancer	0.000298	0.00141	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SMO—brain cancer	0.000296	0.0014	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTCH1—brain cancer	0.000296	0.0014	CbGpPWpGaD
Glycine—SHMT1—Metabolism—IDH1—brain cancer	0.000278	0.00132	CbGpPWpGaD
Glycine—GSS—Metabolism—IDH1—brain cancer	0.000271	0.00128	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ENO2—brain cancer	0.00027	0.00128	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CG—brain cancer	0.000267	0.00126	CbGpPWpGaD
Glycine—SHMT1—Disease—SHH—brain cancer	0.000263	0.00124	CbGpPWpGaD
Glycine—SHMT1—Disease—ENO2—brain cancer	0.000263	0.00124	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000256	0.00121	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CG—brain cancer	0.000242	0.00115	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOTCH2—brain cancer	0.000237	0.00112	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CG—brain cancer	0.000226	0.00107	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VAV1—brain cancer	0.000226	0.00107	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ENO2—brain cancer	0.00022	0.00104	CbGpPWpGaD
Glycine—GSS—Metabolism—ENO2—brain cancer	0.000214	0.00102	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HES1—brain cancer	0.000194	0.000919	CbGpPWpGaD
Glycine—SHMT1—Disease—VAV1—brain cancer	0.00019	0.000899	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—brain cancer	0.000188	0.00089	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PDGFRA—brain cancer	0.000185	0.000875	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SPP1—brain cancer	0.000179	0.000849	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CG—brain cancer	0.000171	0.000811	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CG—brain cancer	0.000171	0.000811	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CG—brain cancer	0.000171	0.000811	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CG—brain cancer	0.000171	0.000811	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—brain cancer	0.000171	0.000808	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CG—brain cancer	0.000163	0.000774	CbGpPWpGaD
Glycine—SHMT1—Disease—HES1—brain cancer	0.000163	0.000773	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IRS2—brain cancer	0.000162	0.000768	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—brain cancer	0.00016	0.000757	CbGpPWpGaD
Glycine—SHMT1—Disease—PDGFRA—brain cancer	0.000155	0.000736	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CG—brain cancer	0.000146	0.00069	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APC—brain cancer	0.000143	0.000678	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CG—brain cancer	0.000143	0.000678	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CG—brain cancer	0.000141	0.000668	CbGpPWpGaD
Glycine—SHMT1—Disease—IRS2—brain cancer	0.000137	0.000646	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—brain cancer	0.000131	0.000618	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CG—brain cancer	0.000124	0.000586	CbGpPWpGaD
Glycine—SHMT1—Disease—APC—brain cancer	0.000121	0.000571	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RELA—brain cancer	0.000112	0.00053	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—brain cancer	0.000111	0.000527	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CG—brain cancer	0.000101	0.000478	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—brain cancer	0.000101	0.000477	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CG—brain cancer	9.84e-05	0.000466	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—brain cancer	9.83e-05	0.000465	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—brain cancer	9.73e-05	0.000461	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—brain cancer	9.36e-05	0.000443	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—brain cancer	8.57e-05	0.000406	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—brain cancer	8.48e-05	0.000402	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—brain cancer	8.19e-05	0.000388	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—brain cancer	7.88e-05	0.000373	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—brain cancer	7.71e-05	0.000365	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—brain cancer	7.14e-05	0.000338	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—brain cancer	6.63e-05	0.000314	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—brain cancer	6.49e-05	0.000307	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—brain cancer	6.47e-05	0.000307	CbGpPWpGaD
